Comparison of STEMI Door-To-Device Time During the COVID-19 Crisis in a New Jersey Inner City Community Hospital

Pravin Thomas1, Natale Wasef1, Muhammed Haq1

  • 1St Francis Medical Center, Trenton, New Jersey.

Insights

The COVID-19 pandemic did not significantly impact door-to-device times for ST-elevation myocardial infarction (STEMI) patients at a community hospital. However, STEMI admissions decreased during the pandemic.

Area of Science:

  • Cardiology
  • Public Health
  • Healthcare Management

Background:

  • The COVID-19 pandemic significantly disrupted healthcare systems globally.
  • Patient reluctance to seek hospital care and postponement of elective procedures were observed.
  • The pandemic's effect on acute cardiac care, specifically ST-elevation myocardial infarction (STEMI) treatment times, required investigation.

Purpose of the Study:

  • To evaluate the impact of the COVID-19 pandemic on door-to-device (D2D) times for STEMI patients.
  • To assess secondary outcomes including hospital stay, ICU admission, and mortality.
  • To analyze changes in STEMI patient volume during the pandemic.

Main Methods:

  • A retrospective study analyzed STEMI cases from January 2018 to May 2021 at a community hospital.
  • Data included 114 STEMI patients: 77 pre-pandemic and 37 during the pandemic.
  • Primary outcome was D2D time; secondary outcomes included length of stay, ICU admission, and mortality.

Main Results:

  • Median D2D time for STEMI cases was 70 minutes both pre-pandemic and during the pandemic (P=0.55).
  • No significant difference in D2D times was observed between the two periods.
  • A significant decrease in the number of STEMI admissions was noted during the pandemic.

Conclusions:

  • The COVID-19 pandemic did not significantly alter door-to-device times for STEMI patients in this community hospital setting.
  • A notable reduction in STEMI admissions occurred during the pandemic.
  • Further research is needed due to study limitations, including small sample size and lack of long-term follow-up.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
23
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
20
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
122